Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Domainex Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10837
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, medicinal chemistry, ADME and DMPK among others. The company’s discovery platform technology enables rapid progression of drug discovery projects from drug target through to candidate drug. It works in partnership with pharma and biotech companies and academic institutions to offer drug discovery expertise and services. Domainex is headquartered in Saffron Walden, the UK.

Domainex Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Domainex Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Partnerships 11
Dotmatics Enters into Agreement with Domainex 11
Johnson Matthey and Domainex Enter into Partnership 12
Domainex Expands its Agreement with Imperial College London 13
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 14
Domainex Extends Co-Development Agreement with Auspherix 15
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 16
Domainex Ltd – Key Competitors 17
Domainex Ltd – Key Employees 18
Domainex Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Jul 19, 2018: Domainex opens for business in Boston and San Diego 20
Corporate Communications 21
Sep 20, 2018: Domainex names Dr Trevor Perrior as Chief Executive Officer 21
Dec 06, 2017: Domainex appoints Chris Brown as Chief Financial Officer 22
Mar 30, 2017: Domainex appoints Timo Veromaa as Executive Chairman 23
Government and Public Interest 24
Jan 23, 2018: Domainex wins award to develop GPCR drug discovery technology 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Domainex Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Dotmatics Enters into Agreement with Domainex 11
Johnson Matthey and Domainex Enter into Partnership 12
Domainex Expands its Agreement with Imperial College London 13
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 14
Domainex Extends Co-Development Agreement with Auspherix 15
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 16
Domainex Ltd, Key Competitors 17
Domainex Ltd, Key Employees 18

List of Figures
Domainex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Consolidated Edison Company of New York Inc:企業の戦略的SWOT分析
    Consolidated Edison Company of New York Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • P.F. Chang’s China Bistro Inc:企業の戦略・SWOT・財務分析
    P.F. Chang's China Bistro Inc - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析
    bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Genae Associates NV:医療機器:M&Aディール及び事業提携情報
    Summary Genae Associates NV (Genae Group) is a medical device CRO that offers clinical trial management services. The organization develops and commercializes investigational products and therapies that advance practices in medicine. Its services comprise clinical trial management, regulatory and sa …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Gas Malaysia Bhd (GASMSIA):企業の財務・戦略的SWOT分析
    Summary Gas Malaysia Bhd (Gas Malaysia) markets and distributes natural gas and liquefied petroleum gas (LPG). The company provides energy solutions which include power generation system with heat recovery such as power and combined heat; and alternative gas distribution such as virtual pipeline. It …
  • AutoNation Inc (AN):企業の財務・戦略的SWOT分析
    AutoNation Inc (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Seibels Bruce Group Inc:企業の戦略・SWOT・財務分析
    The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • KKR Financial Holdings LLC:企業の戦略・SWOT・財務情報
    KKR Financial Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary KKR Financial Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Intersurgical Ltd.:企業の戦略的SWOT分析
    Intersurgical Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Shearman & Sterling LLP:企業の戦略的SWOT分析
    Shearman & Sterling LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Banca Monte dei Paschi di Siena S.p.A.:戦略・SWOT・企業財務分析
    Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Travelport Limited (TVPT):企業の財務・戦略的SWOT分析
    Travelport Limited (TVPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Veloxis Pharmaceuticals AS (VELO):製薬・医療:M&Aディール及び事業提携情報
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company developed ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ reject …
  • Travelsky Technology Ltd (696):企業の財務・戦略的SWOT分析
    Travelsky Technology Ltd (696) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Active Motif Inc-製薬・医療分野:企業M&A・提携分析
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, …
  • Ameresco Inc (AMRC):電力:M&Aディール及び事業提携情報
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆